The Board of Directors of Zoetis
Inc. (NYSE:ZTS) has declared a first quarter 2018 dividend payable
to holders of the company’s common stock of $0.126 per share, an
increase of 20% from the quarterly dividend rate paid in 2017. The
dividend is to be paid on Thursday, March 1, 2018, to holders of record
on Friday, January 19, 2018.
“In 2017, Zoetis has continued to deliver steady, profitable growth
based on our diverse portfolio, improved cost structure and ongoing
investments in innovation,” said Juan Ramón Alaix, Chief Executive
Officer of Zoetis. “We have been able to improve our cash flow
generation based on this performance, and with the Board’s approval, I
am pleased to announce that we are once again increasing our dividend -
by 20% in 2018 - as part of our commitment to returning excess capital
to shareholders.”
About Zoetis
Zoetis
is the leading animal health company, dedicated to supporting its
customers and their businesses. Building on more than 60 years of
experience in animal health, Zoetis discovers, develops, manufactures
and markets veterinary vaccines and medicines, complemented by
diagnostic products, genetic tests, biodevices and a range of services.
Zoetis serves veterinarians, livestock producers and people who raise
and care for farm and companion animals with sales of its products in
more than 100 countries. In 2016, the company generated annual revenue
of $4.9 billion with approximately 9,000 employees. For more
information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements
: This
press release contains forward-looking statements, which reflect the
current views of Zoetis with respect to business plans or prospects,
future operating or financial performance, future use of cash and
dividend payments, and other future events. These statements are not
guarantees of future performance or actions. Forward-looking statements
are subject to risks and uncertainties. If one or more of these risks or
uncertainties materialize, or if management's underlying assumptions
prove to be incorrect, actual results may differ materially from those
contemplated by a forward-looking statement. Forward-looking statements
speak only as of the date on which they are made. Zoetis expressly
disclaims any obligation to update or revise any forward-looking
statement, whether as a result of new information, future events or
otherwise. A further list and description of risks, uncertainties and
other matters can be found in our Annual Report on Form 10-K for the
fiscal year ended December 31, 2016, including in the sections thereof
captioned “Forward-Looking Statements and Factors That May Affect Future
Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on Form
10-Q and in our Current Reports on Form 8-K. These filings and
subsequent filings are available online at
www.sec.gov
,
www.zoetis.com
,
or on request from Zoetis.
Zoetis Inc.
Media:
Elinore White, 1-973-443-2835 (o)
elinore.y.white@zoetis.com
or
Kristen Seely, 1-973-443-2777 (o)
kristen.seely@zoetis.com
or
Investors:
Steve Frank, 1-973-822-7141 (o)
steve.frank@zoetis.com